Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.

about

Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.

Item

http://www.wikidata.org/entity/Q55340553

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@en

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@nl

type

Item

label

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@en

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@nl

prefLabel

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@en

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@nl

P1476

Antineutrophil cytoplasmic ant ...... e remission induction therapy.

@en

P2093

Aris Tsalouchos

http://www.w3.org/2001/XMLSchema#string

Maurizio Salvadori

http://www.w3.org/2001/XMLSchema#string

P2860

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies

Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis

ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature.

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.

P304

71-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5527/WJN.V7.I3.71

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29736379

http://www.w3.org/2001/XMLSchema#string

P932

5937030

http://www.w3.org/2001/XMLSchema#string